Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-01-16 @ 7:16 PM
Study NCT ID:
NCT05826535
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2023-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of LYL314 in Aggressive Large B-Cell Lymphoma
Sponsor:
Lyell Immunopharma, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | CAR T-cell | View |
| None | Non-Hodgkin Lymphoma | View |
| None | CD19/20 | View |
| None | CD19 | View |
| None | CD20 | View |
| None | NHL | View |
| None | Diffuse Large B-cell lymphoma | View |
| None | DLBCL | View |
| None | Transformed follicular lymphoma | View |
| None | TFL | View |
| None | Primary mediastinal B-cell lymphoma | View |
| None | PMBCL | View |
| None | High-grade B-cell lymphoma | View |
| None | HGBL | View |
| None | follicular lymphoma Grade 3B | View |
| None | large cell follicular lymphoma | View |
| None | Aggressive B-cell NHL | View |
| None | Refractory Aggressive B-Cell Lymphoma | View |
| None | Refractory B-Cell Non-Hodgkin Lymphoma | View |
| None | Lymphoma, Non-Hodgkin | View |
| None | Lymphoma | View |
| None | Lymphoma, Large B-Cell, Diffuse | View |
| None | Cyclophosphamide | View |
| None | Fludarabine | View |
| None | Lymphoma, Follicular | View |
| None | Lymphoma, B-cell | View |
| None | Immunosuppressive Agents | View |
| None | Immunologic Factors | View |
| None | Disease Attributes | View |
| None | Immune System Diseases | View |
| None | Recurrence | View |
| None | PiNACLE | View |